What's moving these stocks in pre-market hours today?
In the Green
1. Timber Pharmaceuticals Inc. (TMBR) is up over 22% at $1.78 in pre-market trading Wednesday on no news. The lead drug candidate is TMB-001, which is under a phase 2b study for the treatment of congenital ichthyosis. Also in the pipeline is TMB-002 for the treatment of facial angiofibromas in tuberous sclerosis complex, which is under phase IIb study.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.